Healthcare >> Analyst Interviews >> June 29, 1998

Women’s Health Care : Melissa Wilmoth – Salomon Smith Barney

MELISSA WILMOTH is a Senior Analyst, Medical Technology and Supplies at Salomon Smith Barney. Ms. Wilmoth joined Smith Barney's Research Division in 1996 and covers small capitalization medical technology and supply stocks. She is actively involved in developing M&A and strategic investment ideas for many of Smith Barney's medtech investment banking clients. She is frequently cited in the media for her expertise in women's health. Prior to joining Smith Barney, Ms. Wilmoth was a managing director at Cameron Associates and most of her professional experience has been in the health care industry. Upon receiving her B.A. at the University of Arizona, Ms. Wilmoth began her career in sales at American Hospital Supply in Boston. Following completion of her M.B.A. at the University of Southern California, she was an angioplasty balloon product manager at the USCI division of C.R. Bard where she developed a novel angioplasty balloon catheter. Additionally, Ms. Wilmoth also evaluated emerging technologies for commercial viability including stents, lasers and atherectomy devices. Profile
ANNE MALONE joined Salomon Smith Barney in June, 1996 as a Vice President and Senior Analyst, covering the medical technology industry. Prior to joining Salomon Smith Barney, Ms. Malone worked at Bear, Stearns & Co. for seven years, spending the last three and a half years following medical technology stocks. She is a Chartered Financial Analyst and a member of the New York Society of Analysts. Ms. Malone received a B.A. in Finance with a minor in economics from St. Leo College in June, 1988. Ms. Malone has spent more than seven years in the investment business. Profile
TWST: Melissa, why should women's health care be regarded as a separate

segment of health care?

Ms. Wilmoth: Demographics. If you look at the burden on our health care

system, say, in the